Indication

E. coli lung abscess

An *Escherichia coli* lung abscess is a severe, necrotizing pulmonary infection characterized by the formation of one or more pus-filled cavitary lesions within the lung parenchyma caused by the Gram-negative bacillus *E. Read more about E. coli lung abscess

13 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common E. coli lung abscess therapies.

Showing 1–9 of 13 drugs

Filter & compare in the drug finder →Opens the drug finder with E. coli lung abscess preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About E. coli lung abscess.

An *Escherichia coli* lung abscess is a severe, necrotizing pulmonary infection characterized by the formation of one or more pus-filled cavitary lesions within the lung parenchyma caused by the Gram-negative bacillus *E.

coli*.

Typically affecting the lower respiratory tract, it predominantly occurs in hospitalized, debilitated, or immunocompromised patients, as well as individuals predisposed to aspiration of gastrointestinal secretions or hematogenous seeding from an extrapulmonary focus, such as a urinary tract or intra-abdominal infection.

Pathophysiologically, the organism incites intense local inflammation leading to liquefactive tissue necrosis, cavity formation, and air-fluid levels visible on chest imaging.

Patients commonly present with productive cough yielding purulent or foul-smelling sputum, high fever, chills, pleuritic chest pain, leukocytosis, and constitutional symptoms like fatigue and weight loss.

Personalize your experience

Follow E. coli lung abscess and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it